Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)

John Bartlett

doi:10.1097/01.idc.0000130889.35482.ee

Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)

John Bartlett

Johns Hopkins Health System

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Number of pages	1
Journal	Infectious Diseases in Clinical Practice
Volume	12
Issue number	4
DOIs	https://doi.org/10.1097/01.idc.0000130889.35482.ee
State	Published - Jan 1 2004

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1097/01.idc.0000130889.35482.ee

Cite this

Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study). / Bartlett, John.
In: Infectious Diseases in Clinical Practice, Vol. 12, No. 4, 01.01.2004.

Research output: Contribution to journal › Article › peer-review

@article{5f51b68232b14e5d8f070dc61dd7a016,

title = "Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)",

author = "John Bartlett",

year = "2004",

month = jan,

day = "1",

doi = "10.1097/01.idc.0000130889.35482.ee",

language = "English (US)",

volume = "12",

journal = "Infectious Diseases in Clinical Practice",

issn = "1056-9103",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)

AU - Bartlett, John

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=85026142434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026142434&partnerID=8YFLogxK

U2 - 10.1097/01.idc.0000130889.35482.ee

DO - 10.1097/01.idc.0000130889.35482.ee

M3 - Article

AN - SCOPUS:85026142434

SN - 1056-9103

VL - 12

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

IS - 4

ER -

Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this